These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28034372)

  • 1. Public health response to the silent reintroduction of wild poliovirus to Israel, 2013-2014.
    Moran-Gilad J; Kaliner E; Gdalevich M; Grotto I
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S140-S145. PubMed ID: 28034372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent reintroduction of wild-type poliovirus to Israel, 2013 - risk communication challenges in an argumentative atmosphere.
    Kaliner E; Moran-Gilad J; Grotto I; Somekh E; Kopel E; Gdalevich M; Shimron E; Amikam Y; Leventhal A; Lev B; Gamzu R
    Euro Surveill; 2014 Feb; 19(7):20703. PubMed ID: 24576475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel.
    Moran-Gilad J; Mendelson E; Burns CC; Bassal R; Gdalevich M; Sofer D; Oberste MS; Shulman LM; Kaliner E; Hindiyeh M; Mor O; Shahar L; Iber J; Yishay R; Manor J; Lev B; Gamzu R; Grotto I
    J Clin Virol; 2015 May; 66():51-5. PubMed ID: 25866337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
    Kalkowska DA; Duintjer Tebbens RJ; Grotto I; Shulman LM; Anis E; Wassilak SG; Pallansch MA; Thompson KM
    J Infect Dis; 2015 Jun; 211(11):1800-12. PubMed ID: 25505296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013.
    Shulman LM; Mendelson E; Anis E; Bassal R; Gdalevich M; Hindiyeh M; Kaliner E; Kopel E; Manor Y; Moran-Gilad J; Ram D; Sofer D; Somekh E; Tasher D; Weil M; Gamzu R; Grotto I
    J Infect Dis; 2014 Nov; 210 Suppl 1():S304-14. PubMed ID: 25316849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(44):899-904. PubMed ID: 23134973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013.
    Manor Y; Shulman LM; Kaliner E; Hindiyeh M; Ram D; Sofer D; Moran-Gilad J; Lev B; Grotto I; Gamzu R; Mendelson E
    Euro Surveill; 2014 Feb; 19(7):20708. PubMed ID: 24576473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination.
    Kalkowska DA; Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Thompson KM
    BMC Infect Dis; 2015 Feb; 15():66. PubMed ID: 25886823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013.
    Shulman LM; Gavrilin E; Jorba J; Martin J; Burns CC; Manor Y; Moran-Gilad J; Sofer D; Hindiyeh MY; Gamzu R; Mendelson E; Grotto I;
    Euro Surveill; 2014 Feb; 19(7):20709. PubMed ID: 24576471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Israeli public health response to wild poliovirus importation.
    Kaliner E; Kopel E; Anis E; Mendelson E; Moran-Gilad J; Shulman LM; Singer SR; Manor Y; Somekh E; Rishpon S; Leventhal A; Rubin L; Tasher D; Honovich M; Moerman L; Shohat T; Bassal R; Sofer D; Gdalevich M; Lev B; Gamzu R; Grotto I
    Lancet Infect Dis; 2015 Oct; 15(10):1236-1242. PubMed ID: 26213249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):357-62. PubMed ID: 19373195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward poliomyelitis eradication--Chad, January 2011-August 2012.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(42):858-62. PubMed ID: 23095955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.
    Brouwer AF; Eisenberg JNS; Pomeroy CD; Shulman LM; Hindiyeh M; Manor Y; Grotto I; Koopman JS; Eisenberg MC
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10625-E10633. PubMed ID: 30337479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insidious reintroduction of wild poliovirus into Israel, 2013.
    Anis E; Kopel E; Singer SR; Kaliner E; Moerman L; Moran-Gilad J; Sofer D; Manor Y; Shulman LM; Mendelson E; Gdalevich M; Lev B; Gamzu R; Grotto I
    Euro Surveill; 2013 Sep; 18(38):. PubMed ID: 24084337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress Toward Poliomyelitis Eradication - Pakistan, January 2015-September 2016.
    Hsu CH; Mahamud A; Safdar RM; Ahmed J; Jorba J; Sharif S; Farag N; Martinez M; Tangermann RH; Ehrhardt D
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(46):1295-1299. PubMed ID: 27880752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characterization of Polio from Environmental Samples: ISSP, The Israeli Sewage Surveillance Protocol.
    Shulman LM; Manor Y; Hindiyeh M; Sofer D; Mendelson E
    Methods Mol Biol; 2016; 1387():55-107. PubMed ID: 26983731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
    Chowdhary R; Dhole TN
    J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.